Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy
Authors:
Open Access
- 20 June 2018
- journal article
- research article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 35 (1) , 90-96
Abstract
Introduction: The targeting of hepatocellular carcinomas (HCC) in the hepatic dome can be challenging during percutaneous thermal ablation (PTA). The aims of this study were (1) to evaluate the safety and efficacy of PTA of HCC in the hepatic dome that cannot be visualized under US, using artificial CO2 pneumothorax and CT-guidance and (2) to compare the results with US-visible HCC located in the liver dome treated under US-guidance. Materials: Over a 32-month period, 56 HCC located in the hepatic dome were extracted from a prospectively maintained database. Twenty-eight cases (US-guidance group) were treated under US-guidance, while the others (n = 28, CT-CO2 group) were treated under CT-guidance using artificial CO2 pneumothorax after lipiodol tagging of the tumor. The primary technical success and complications rates of this technique were retrospectively assessed. Local tumor progression (LTP), intrahepatic distant recurrence (IDR), local recurrence-free survival (LRFS) and overall survival (OS) were also compared between both groups. Results: Primary technical success was 100% in both groups. No major complications occurred. After a median follow-up of 13.8 months (range, 1–33.4 months), LTP occurred in 10.7% (3/28) in CT-CO2 vs. 25% (7/28) in the US-guidance group (p = NS). IDR occurred in 39.3% (11/28) in CT-CO2 vs. 28.6% (8/28) in the US-guidance group (p = NS). Death occurred in 17.9% (5/28) of patients in both groups. LRFS and OS did not significantly differ using Kaplan-Meier survival estimates. Conclusion: CT-guided PTA after artificially induced CO2 pneumothorax is a safe and efficient technique to treat HCC located in the hepatic dome.Keywords
This publication has 26 references indexed in Scilit:
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic FactorsAmerican Journal of Gastroenterology, 2012
- Technique for Creation of Artificial Pneumothorax for Pain Relief during Radiofrequency Ablation of Peripheral Lung Tumors: Report of Seven CasesJournal of Vascular and Interventional Radiology, 2011
- Society of Interventional Radiology Clinical Practice GuidelinesJournal of Vascular and Interventional Radiology, 2009
- Image-guided Tumor Ablation: Standardization of Terminology and Reporting CriteriaJournal of Vascular and Interventional Radiology, 2009
- Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion techniqueBritish Journal of Surgery, 2008
- Thinking Outside the Abdominal Box: Safe Use of the Epipericardial Fat Pad Window for Percutaneous Radiofrequency Ablation of Hepatic Dome TumorsJournal of Vascular and Interventional Radiology, 2008
- Air Embolism during Needle Placement for CT-guided Radiofrequency Ablation of an Unresectable Metastatic Lung LesionJournal of Vascular and Interventional Radiology, 2007
- Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factorsEuropean Journal of Radiology, 2006
- Early and Late Complications After Radiofrequency Ablation of Malignant Liver Tumors in 608 PatientsAnnals of Surgery, 2004
- Neues Instrument zur Ausführung von Brust- oder Bauchpunktionen und PneumothoraxbehandlungDMW - Deutsche Medizinische Wochenschrift, 1938